AI in Breast Cancer Screening, Journavx Update, and Omega-3's Role in Aging

In this episode, Dr. Chi-Ming Chow opens with a discussion on the impact of tariffs on healthcare, particularly focusing on nursing homes and the associated costs. He then explores a UK breast cancer screening trial that utilizes artificial intelligence, highlighting its potential benefits. The episode introduces Journavx, a new non-opioid pain medication, followed by insights from the DO-HEALTH trial on how Omega-3 influences biological aging. Dr. Chow concludes by examining the challenges and efforts involved in preserving federal health data in the United States, emphasizing the importance of safeguarding this vital information.